Matches in Wikidata for { <http://www.wikidata.org/entity/Q80317830> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q80317830 description "article scientifique publié en 2007" @default.
- Q80317830 description "artículu científicu espublizáu en xunu de 2007" @default.
- Q80317830 description "im Juni 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80317830 description "scientific article published on 01 June 2007" @default.
- Q80317830 description "wetenschappelijk artikel" @default.
- Q80317830 description "наукова стаття, опублікована в червні 2007" @default.
- Q80317830 name "Possible increased risk of pulmonary edema in patients with hepatorenal syndrome on adding octreotide to albumin / noradrenaline therapies" @default.
- Q80317830 name "Possible increased risk of pulmonary edema in patients with hepatorenal syndrome on adding octreotide to albumin / noradrenaline therapies" @default.
- Q80317830 type Item @default.
- Q80317830 label "Possible increased risk of pulmonary edema in patients with hepatorenal syndrome on adding octreotide to albumin / noradrenaline therapies" @default.
- Q80317830 label "Possible increased risk of pulmonary edema in patients with hepatorenal syndrome on adding octreotide to albumin / noradrenaline therapies" @default.
- Q80317830 prefLabel "Possible increased risk of pulmonary edema in patients with hepatorenal syndrome on adding octreotide to albumin / noradrenaline therapies" @default.
- Q80317830 prefLabel "Possible increased risk of pulmonary edema in patients with hepatorenal syndrome on adding octreotide to albumin / noradrenaline therapies" @default.
- Q80317830 P1433 Q80317830-1CDF538A-5448-4E5C-B109-DE041BFDB675 @default.
- Q80317830 P1476 Q80317830-85808E9A-E934-4F4E-A2A9-372E991A9520 @default.
- Q80317830 P2093 Q80317830-416C0EF1-3921-4A16-BB5A-974FC6A29B8A @default.
- Q80317830 P304 Q80317830-37EF04B9-C233-46A2-BFF5-D5D39AC312C4 @default.
- Q80317830 P31 Q80317830-9323BC19-FF5E-483C-8D09-D9D902C21DB8 @default.
- Q80317830 P433 Q80317830-09D9BE0E-1D1E-451F-B1B9-E1BC77250165 @default.
- Q80317830 P478 Q80317830-F5F58EEB-C702-4B10-BE3B-9027579FD0FD @default.
- Q80317830 P577 Q80317830-7E79CEC2-E08A-4298-81E1-FCDD1E0E04E1 @default.
- Q80317830 P698 Q80317830-28CF3CDF-3F74-4E3B-9FFE-CE8E85AF76DD @default.
- Q80317830 P921 Q80317830-1BE13358-8104-494C-B7D4-09A87DFD5D42 @default.
- Q80317830 P921 Q80317830-52A10DDE-2BA3-4235-B93A-C1456A48F936 @default.
- Q80317830 P921 Q80317830-7F460DDD-6140-4169-B158-F8B1CF37AC4B @default.
- Q80317830 P698 17496406 @default.
- Q80317830 P1433 Q26854013 @default.
- Q80317830 P1476 "Possible increased risk of pulmonary edema in patients with hepatorenal syndrome on adding octreotide to albumin / noradrenaline therapies" @default.
- Q80317830 P2093 "Nasrulla Abutaleb" @default.
- Q80317830 P304 "261" @default.
- Q80317830 P31 Q13442814 @default.
- Q80317830 P433 "2" @default.
- Q80317830 P478 "18" @default.
- Q80317830 P577 "2007-06-01T00:00:00Z" @default.
- Q80317830 P698 "17496406" @default.
- Q80317830 P921 Q186242 @default.
- Q80317830 P921 Q247131 @default.
- Q80317830 P921 Q857667 @default.